logo

For the Inventor, By the Inventor

Toyama, Japan

Takako Hori

USPTO Granted Patents = 13

Average Co-Inventor Count = 7.5

ph-index = 4

Forward Citations = 37(Granted Patents)


Company Filing History:

goldMedal13 out of 159 
 
Toyama Chemical Co., Ltd.
 patents

Years Active: 1984-1992

Loading Chart...
13 patents (USPTO):Explore Patents
1. 5166204 - Isoindole derivatives and salts thereof and antitumor agent comprising (1992-11-24),
2. 4744985 - Novel substances having carcinostatic and immunostimulating activity, (1988-05-17),
3. 4740503 - Novel 5-fluoro-2'-deoxyuridine derivatives and salts thereof, process (1988-04-26),
4. 4684631 - Novel 5-fluoro-2-deoxyuridine derivatives and salts thereof, process for (1987-08-04),
5. 4591558 - Novel substances having antitumor and immunostimulating activity, (1986-05-27),
6. 4547462 - Process for preparing substance having carcinostatic and (1985-10-15),
7. 4477666 - 1-(4-Aminobenzyl)-2,3-dioxopiperazine derivatives, acid addition salts (1984-10-16),
8. 4477664 - Novel 1-(4-piperidiniobenzyl)-2,3-dioxopiperazine derivatives or acid (1984-10-16),
9. 4477437 - Substances having carcinostatic and immunostimulating activity (1984-10-16),
10. 4460774 - 1-(4-Aminobenzyl)-2,3-dioxopiperazine derivatives, acid addition salts (1984-07-17),
11. 4459407 - 1-(4-Aminobenzyl)-2,3-dioxopiperazine derivatives and salts thereof (1984-07-10),
12. 4448963 - 4-[4-(Thiazolyl-amino)benzyl]-2,3-dioxopiperazine derivatives, acid (1984-05-15),
13. 4436921 - 1-(4-Aminobenzyl)-2,3-dioxopiperazine derivatives, acid addition salts (1984-03-13),

Title: The Innovative Contributions of Takako Hori

Introduction

Takako Hori is a prominent inventor based in Toyama, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic potential. With a total of 13 patents to her name, Hori's work has garnered attention for its innovative approaches to cancer treatment.

Latest Patents

Hori's latest patents include isoindole derivatives and salts thereof, which serve as antitumor agents. One notable invention is a novel isoindole derivative represented by a specific general formula, which exhibits excellent antitumor activity while maintaining low toxicity. Additionally, she has developed novel substances that possess carcinostatic and immunostimulating activity. These substances are derived from cultures of bacteria belonging to the Fusobacterium genus and are useful in treating cancerous diseases in lower warm-blooded animals. This disclosure outlines the substances and the process for their preparation, as well as a carcinostatic agent that incorporates these innovative compounds.

Career Highlights

Hori is currently employed at Toyama Chemical Co., Ltd., where she continues to advance her research and development efforts. Her work has not only contributed to the scientific community but has also paved the way for new therapeutic options in oncology.

Collaborations

Hori has collaborated with notable colleagues, including Isamu Saikawa and Shohachi Murakami. These partnerships have enhanced her research endeavors and fostered a collaborative environment for innovation.

Conclusion

Takako Hori's contributions to the field of pharmaceuticals, particularly in cancer treatment, highlight her role as a leading inventor. Her innovative patents and collaborative efforts continue to impact the scientific community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…